A significant group effect was observed on the number of RUNX2-positive cancer cells (p=0.0187), after which post hoc testing showed significantly in BM− (375.4 ± 20.97) respect to BL (273.3 ± 27.14) (p=0.0006). The gene discussed is RUNX2; the disease is cancer.